Patent Oppositions in digestive drugs industry

Explore the competitive field of digestive drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in digestive drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the digestive drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the digestive drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 24, 2026NUTRICIA
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 19, 2026ZIMMERMANN & PARTNER PATENTANWALTE MBB
Acidic Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 17, 2026GLEISS GROSSE SCHRELL UND PARTNER MBB
Acidic Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 16, 2026ZIMMERMANN & PARTNER PATENTANWALTE MBB
Ph Neutral Beta-Lactoglobulin Beverage PreparationARLA FOODS AMBAJun 16, 2026FRIESLANDCAMPINA NEDERLAND
Drug Delivery Systems And Methods For Treatment Of Bladder Cancer With GemcitabineTARIS BIOMEDICALJun 10, 2026GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBB
Beta-1,3'-Galactosyllactose For The Treatment Of Gut Barrier Function DiseasesNUTRICIAMay 19, 2026NESTLE
Bacteriotherapy For Clostridium Difficile ColitisREBIOTIXMay 19, 2026PLASSERAUD
Neutralization Of Inhibitory Pathways In LymphocytesINNATE PHARMAMay 13, 2026STRAWMAN
Methods For Treating Nasal Polyposis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSMay 6, 2026ENGELHARD

To stay ahead in the competitive digestive drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the digestive drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY24
Jan 7, 2026Formulations Of EnzalutamideASTELLAS PHARMA14
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS11
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS10
Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS9
Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM9
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS8
May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP8
Nov 30, 2022Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) InhibitorNOVARTIS8
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALS8